ROSWELL, GA, February 24, 2025 – Sebela Women’s Health Inc., a part of Sebela Pharmaceuticals...
Category - New Drugs
FDA Approves Ctexli (chenodiol) for Cerebrotendinous...
February 21, 2025 — Today, the U.S. Food and Drug Administration approved Ctexli (chenodiol)...
FDA Approves Merilog (insulin-aspart-szjj), a Biosimilar to NovoLog
FDA Approves Xbryk (denosumab-dssb), a Biosimilar to Xgeva
FDA Approves Ospomyv (denosumab-dssb), a Biosimilar to Prolia
FDA Approves Penmenvy (meningococcal groups A, B, C, W, and Y vaccine) for Prevention of Invasive Meningococcal Disease Caused by Serogroups A, B, C, W, and Y
FDA Approves Vimkunya (chikungunya vaccine, recombinant) for Prevention of Disease Caused by Chikungunya Virus
FDA Approves Romvimza (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor
U.S. FDA Approves Expanded Label for Astellas’ Izervay (avacincaptad pegol intravitreal solution) for Geographic Atrophy